The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Cancer registration in China and its role in cancer prevention and control
Abstract
Cancer has become a leading cause of death in China, with an increasing burden of cancer incidence and mortality observed over the past half century. Population-based cancer registries have been operating in China for about 60 years, and, in 2018, their role has expanded to include the formulation and evaluation of national cancer control programmes and the care of patients with cancer. The purpose of this Review is to provide an overview of the key milestones in the development of cancer registration in China, the current status of registry coverage and quality, and a description of the changing cancer profile in China from 1973 to 2015. This Review is a comprehensive and updated review on the development of population-based cancer registries in China over a 60-year time span. We highlight some aspects of cancer control plans that illustrate how cancer registration data have become central to the identification of health priorities for China and provide a means to track progress in cancer control for the country.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Self-citationCancer statistics in China, 2015
Chen, W., Zheng, R., Baade, P. D., Zhang, S., Zeng, H., Bray, F., Jemal, A., Yu, X. Q., & He, J. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21338 · Cited by 17,038
Self-citationTangka, F. K. L., Subramanian, S., Edwards, P., Cole-Beebe, M., Parkin, D. M., Bray, F., Joseph, R., Mery, L., & Saraiya, M. (2016) · Cancer Epidemiology · doi:10.1016/j.canep.2016.10.009 · Cited by 36
Self-citation
Cited by
Cancer statistics in China and United States, 2022: profiles, trends, and determinants
Xia, C., Dong, X., Li, H., Cao, M., Sun, D., He, S., Yang, F., Yan, X., Zhang, S., Li, N., et al. (2022) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002108 · Cited by 3,402
Self-citationCancer incidence and mortality in China, 2022
Han, B., Zheng, R., Zeng, H., Wang, S., Sun, K., Chen, R., Li, L., Wei, W., & He, J. (2024) · Journal of the National Cancer Center · doi:10.1016/j.jncc.2024.01.006 · Cited by 2,243
Self-citationGlobal burden of primary liver cancer in 2020 and predictions to 2040
Rumgay, H., Arnold, M., Ferlay, J., Lesi, O., Cabasag, C. J., Vignat, J., Laversanne, M., McGlynn, K. A., & Soerjomataram, I. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.08.021 · Cited by 2,197
Cancer incidence and mortality in China, 2016
Zheng, R., Zhang, S., Zeng, H., Wang, S., Sun, K., Chen, R., Li, L., Wei, W., & He, J. (2022) · Journal of the National Cancer Center · doi:10.1016/j.jncc.2022.02.002 · Cited by 1,494
Self-citationFilho, A. M., Laversanne, M., Ferlay, J., Colombet, M., Piñeros, M., Znaor, A., Parkin, D. M., Soerjomataram, I., & Bray, F. (2025) · International Journal of Cancer · doi:10.1002/ijc.35278 · Cited by 892
Self-citation
Metadata
- Authors
- Wei, W., Zeng, H., Zheng, R., Zhang, S., An, L., Chen, R., Wang, S., Sun, K., Matsuda, T., Bray, F., & He, J.
- Venue
- The Lancet Oncology
- Publisher
- Elsevier BV
- Published
- 2020-07
- Volume
- 21
- Issue
- 7
- Pages
- e342-e349
- ISSN
- 1470-2045 (ISSN-L)
- OpenAlex
- W3038004940
- Cited by
- 497
- References
- 3
- FWCI
- 22.30
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cancer registration in China and its role in cancer prevention and control. https://app.cochat.ai/papers/10.1016/s1470-2045(20)30073-5
- The paper
- Wei, W., Zeng, H., Zheng, R., Zhang, S., An, L., Chen, R., Wang, S., Sun, K., Matsuda, T., Bray, F., & He, J. (2020). Cancer registration in China and its role in cancer prevention and control. The Lancet Oncology. https://doi.org/10.1016/s1470-2045(20)30073-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
